PMC:7696151 / 34846-35078
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1038","span":{"begin":171,"end":179},"obj":"Species"},{"id":"1045","span":{"begin":4,"end":7},"obj":"Chemical"}],"attributes":[{"id":"A1038","pred":"tao:has_database_id","subj":"1038","obj":"Tax:9606"},{"id":"A1045","pred":"tao:has_database_id","subj":"1045","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The HCQ administration (400 mg day) as post-exposure prophylaxis resulted in the negative follow-up PCR tests after the end of 14 days of quarantine period (only 97.4% of patients and 95.5% of care-workers completed the study) [40]."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T231","span":{"begin":0,"end":232},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The HCQ administration (400 mg day) as post-exposure prophylaxis resulted in the negative follow-up PCR tests after the end of 14 days of quarantine period (only 97.4% of patients and 95.5% of care-workers completed the study) [40]."}